Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma
Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma have?
Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma has 52 citations in the OpenAlex counts ScholarIQ stores.
When was Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma published?
Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma has 2010 year in the ScholarIQ index.
What is the open-access status of Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma?
Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma has bronze oa status in the ScholarIQ index.
What is the DOI of Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma?
The DOI for Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma is on the source record.
What is the PMID of Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma?
The PMID for Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma is on the source record.
What is the OpenAlex record for Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma?
The OpenAlex for Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma is on the source record.